Bromocriptine (Parlodel)

2810  relevant articles (290 outcomes, 309 trials/studies) found for this Drug

Parlodel; Bromocriptin; CB154; 2-Bromo-alpha-ergocryptine; 2-Bromo-alpha-ergokryptine; 2-Bromoergocryptine Mesylate; 2-Bromoergocryptine Methanesulfonate; 2-Bromoergokryptine; Bromocriptine Mesylate; CB-154; 2 Bromo alpha ergocryptine; 2 Bromo alpha ergokryptine; 2 Bromoergocryptine; 2 Bromoergocryptine Mesylate; 2 Bromoergocryptine Methanesulfonate; 2 Bromoergokryptine; CB 154; Mesylate, 2-Bromoergocryptine; Mesylate, Bromocriptine; Methanesulfonate, 2-Bromoergocryptine; 2-Bromoergocryptine; Bromocryptin; Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-

Relationship Network

Drug Context: Research Results

Related Diseases

1.	Parkinson Disease (Parkinson's Disease) 01/01/1990 - "This multicentre double-blind study compared the efficacy of low and very low dose bromocriptine in 64 elderly subjects with newly diagnosed Parkinson's disease" 01/01/1988 - "For many years, bromocriptine has proven to be a useful treatment for some of the disabling motor effects seen in Parkinson's disease" 06/01/1985 - "Bromocriptine, in low doses, is effective in patients with mild to moderate Parkinson's disease, while bromocriptine in higher doses is needed in patients with advanced disease" 01/01/1997 - "A 10-year nationwide multicenter prospective study on the long-term efficacy of bromocriptine for Parkinson's disease is reported" 08/11/1986 - "These findings may, in part, explain the long-term clinical efficacy of bromocriptine in patients with Parkinson's disease." Get all the results and reference details, order at left...
2.	Prolactinoma (Prolactinomas) 07/01/1981 - "In a case of sESS consecutive to the treatment with bromocriptine (for 6 months) of an invasive prolactinoma, TRH i. v. released PRL into the CSF but not into the blood, and the serum/ CSF ratio of PRL was very low, until a new cure with bromocriptine (for 3 months) mormalised it" 06/15/1987 - "The therapy with bromocriptine reveals good results particularly in prolactinomas." 08/01/2004 - "CONCLUSION: the favourable response obtained in this patient implies that bromocriptine monotherapy can be an effective first-line treatment for children with prolactinoma." 06/01/1995 - "CONCLUSION: It is concluded that bromocriptine LAR is an effective treatment in the majority of patients with macroprolactinomas; it is also partially effective in some patients with GH secreting macroadenomas." 12/01/1993 - "Macroprolactinomas are pituitary tumours which have been effectively treated medically since the introduction of bromocriptine" Get all the results and reference details, order at left...
3.	Neoplasms (Cancer) 11/01/1994 - "Case 1 was treated with bromocriptine, leading to marked decrease in serum PRL levels and reduction of tumor size" 02/01/2005 - "The combination of surgery and radiotherapy, as well as medical therapy with bromocriptine, achieves good results in the management of these uncommon tumors." 03/01/2003 - "The patient was treated with bromocriptine and has shown a rapid improvement in her visual field and a regression of the tumor, as evidenced by a repeat MRI" 07/01/1997 - "The frequencies of bromocriptine-resistant tumors (30 vs.5%; P < 0.01) and invasive macroadenomas (52 vs.27%; P < 0.001) were significantly greater in men than those in women" 12/01/1984 - "A single dose of 5 mg bromocriptine elicited a significant reduction in FSH levels from 137 to 64 mIU/ml. Long term treatment with 15 mg/day bromocriptine resulted in further reduction of FSH level, to 36.4 mIU/ml, without any change in tumor size" Get all the results and reference details, order at left...
4.	Hyperprolactinemia 09/01/2003 - "CONCLUSIONS: Oral bromocriptine for 2 weeks in postpartum patients with SLE may relieve the disease from hyperprolactinemia and hyperestrogenemia, and may be beneficial in protecting the patients from disease relapse and in reducing the usage of steroid and immunosuppressant." 02/01/1989 - "In 13 patients PRL levels were maintained within the normal range with daily administration of 2.5 mg, whereas in two patients, PRL levels remained higher than normal despite an increase in bromocriptine dose to 5 mg. These results suggest that short term use of vaginal bromocriptine is a safe and effective method of therapy for hyperprolactinemia." 09/01/1993 - "Therapeutic efficacy of vaginal administration of bromocryptin in patients with hyperprolactinemia]" 06/01/1993 - "The administration of bromocriptine (4 mg/kg.day) to these animals was effective in suppressing pituitary weight and hyperprolactinemia and mitigated the lateral prostate inflammatory response" 07/01/1992 - "Treatment of his hyperprolactinemia with bromocriptine did not improve his fertility; however, concurrent treatment of both conditions resulted in improved semen quality, conception, and the birth of a healthy baby girl." Get all the results and reference details, order at left...
5.	Dyskinesias (Dyskinesia) 01/01/1994 - "Of 22 patients who had been on bromocriptine monotherapy for 7 years (group B), 16 remained improved or remained in the same stages of Hoehn and Yahr, and no wearing-off phenomenon or dyskinesia was observed" 10/01/1985 - "Twelve patients with a long-standing history of moderate to severe symptoms of tardive dyskinesia, which had remained stable for several months, participated in a 6-week trial with bromocriptine" 09/01/1977 - "Dyskinesia, occurring during bromocriptine treatment in 9 of 11 patients, disappeared within the period of study in 6 patients after dose reduction without changes in Parkinson disability scores to placebo level" 01/01/2008 - "Ergots (apart from bromocriptine) stimulate the DA D(1) subreceptor and increase dyskinesia" 02/12/2007 - "Only AIMs, however, provided a specific measure of dyskinesia since rotations also were induced by bromocriptine, a drug with low dyskinesiogenic potential" Get all the results and reference details, order at left...
421 Diseases and 2810 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Levodopa (L Dopa)
2.	Prolactin
3.	Pergolide (Permax)
4.	Dopamine Agonists (Dopamine Agonist)
5.	Bromocriptine (Parlodel)
6.	cabergoline
7.	Glucose (Dextrose)
8.	Octreotide (Sandostatin)
9.	ropinirole (Requip)
10.	Clomiphene (Clomifene)
528 Drugs and Important Bio-Agents and 1574 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Aftercare (After-Treatment)
3.	Pituitary Irradiation
4.	Hypophysectomy
5.	Activities of Daily Living (ADL)
56 Therapies and Procedures and 127 more articles analyzed in the Research Interface, order at left...